InvestorsHub Logo
Followers 90
Posts 17406
Boards Moderated 0
Alias Born 09/06/2006

Re: CrashOverride post# 485645

Saturday, 06/11/2022 1:49:53 PM

Saturday, June 11, 2022 1:49:53 PM

Post# of 700641
$25B for 20%, sure.

Let me ask you a question. The recent data is no better than the 2018 data, and arguably worse. So per you BP has known this is a $500B franchise for years.

Why have they not started trials with ATL-DCs? Orphan designation will protect the GBM indication, but not others. The patents on -L will expire well before any additional indications come to market. On manufacturing, BP has been pumping billions into the space.

So why not spend a few hundred million to have a shot on the rest of the cancers outside of brain? Are they stupid?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News